查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1775545

全球數位病理學市場預測（2025-2030）

Digital Pathology Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球數位病理學市場預計將從 2025 年的 1,078,255,000 美元成長到 2030 年的 2,305,011,000 美元，複合年成長率為 16.41%。

本研究報告對全球數位病理學市場進行了全面分析，為行業專業人士提供了關於塑造這一變革性醫療保健行業的市場趨勢、技術進步和競爭策略的關鍵見解。報告探討了關鍵的市場動態，包括市場促進因素、限制因素和機會，並按產品類型、最終用戶、應用和地區進行了詳細細分。我們對數位病理學市場的研究旨在支援策略決策，提供數據驅動的預測、監管考慮和競爭情報，幫助相關人員應對不斷變化的數位病理學解決方案格局。

調查概述

本報告按產品類型（掃描器、軟體、資訊管理系統、儲存和雲端解決方案、通訊和網路系統）、最終用戶（醫院、診斷實驗室、製藥和生物技術公司、學術和研究機構、受託研究機構）、應用（藥物發現和開發、疾病診斷、學術研究、遠距病理學、培訓和教育）和地區市場（北美、南美、歐洲、中東和非洲、亞太地區）研究全球數位病理市場（北美、南美、歐洲、中東和非洲、亞太地區）。除了包括波特五力分析、產業價值鏈分析和市場佔有率評估在內的強大分析之外，該報告還包括策略建議和監管見解，以幫助相關人員利用成長機會。它強調了關鍵促進因素，例如病理學中人工智慧的應用和對遠距離診斷的需求，以及挑戰，例如高實施成本和監管複雜性。

競爭格局與分析

數位病理學市場研究的競爭情報部分強調了主要企業為提升其市場佔有率而採取的策略性舉措。例如，徠卡生物系統公司 Nussloch GmbH（丹納赫）於 2024 年推出了其 Aperio GT 450 DX 掃描儀的升級版，增強了人工智慧主導的影像分析功能，以便美國各地的診斷實驗室更快診斷疾病。這項發展加強了徠卡生物系統在高通量掃描解決方案方面的領導地位。同樣，荷蘭皇家飛利浦公司於 2025 年透過與歐洲領先的醫院網路建立策略合作夥伴關係擴展了其數位病理學產品組合，並將其 IntelliSite 平台與雲端基礎的儲存解決方案相結合，以增強德國和法國的遠端病理學服務。該研究還包括市場佔有率分析、併購以及提供競爭格局整體情況的競爭儀表板。

結論

這份研究報告是業界專業人士了解數位病理學市場複雜性的必備資源。透過提供詳細的細分市場、技術格局和競爭情報，本研究為識別機會和製定有效策略提供了堅實的框架。徠卡生物系統公司（Leica Biosystems Nussloch GmbH）和荷蘭皇家飛利浦公司（Koninklijke Philips NV）等領先公司正在推動人工智慧掃描和雲端整合遠端病理學解決方案的技術創新，數位病理學市場的競爭正幫助相關人員在這個充滿活力且快速發展的行業中保持競爭力。

本報告的主要優點

  • 深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分領域。
  • 競爭格局：了解主要企業正在採取的策略舉措，並了解正確策略的市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力來提供策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾範圍廣：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具成本效益的。

報告的主要用途

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2022-2024年實際數據及2025-2030年預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 各地區（包括細分市場和國家）的收益成長和預測分析
  • 公司簡介（主要包括策略、產品、財務資訊、主要發展動態等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章數位病理學市場（按產品類型）

  • 介紹
  • 掃描器
  • 軟體
  • 資訊管理系統
  • 儲存和雲端解決方案
  • 通訊與網路系統

第6章：數位病理學市場（按最終用戶）

  • 介紹
  • 醫院
  • 診斷實驗室
  • 製藥和生物技術公司
  • 學術和研究機構
  • 受託研究機構（CRO）

第7章數位病理學市場（按應用）

  • 介紹
  • 藥物發現與開發
  • 疾病診斷
  • 學術研究
  • 遠端病理學
  • 培訓和教育

第 8 章：按地區分類的數位病理學市場

  • 介紹
  • 北美洲
    • 依產品類型
    • 按最終用戶
    • 按用途
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依產品類型
    • 按最終用戶
    • 按用途
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依產品類型
    • 按最終用戶
    • 按用途
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依產品類型
    • 按最終用戶
    • 按用途
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依產品類型
    • 按最終用戶
    • 按用途
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章：競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 併購、協議和合作
  • 競爭對手儀表板

第10章：公司簡介

  • Leica Biosystems Nussloch GmbH（Danaher）
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips NV
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies, Inc.
  • Epredia（3DHISTECH Ltd.）
  • Visiopharm A/S
  • Huron Technologies International Inc.
  • ContextVision AB

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061610505

The Digital Pathology Market is expected to grow from USD 1,078.255 million in 2025 to USD 2,305.011 million in 2030, at a CAGR of 16.41%.

The Digital Pathology Market Study delivers a comprehensive analysis of the global digital pathology market, providing industry experts with critical insights into market trends, technological advancements, and competitive strategies shaping this transformative healthcare sector. This study explores key market dynamics, including drivers, restraints, and opportunities, with detailed segmentation by product type, end-user, application, and geography. Designed to support strategic decision-making, the Digital Pathology Market Study equips stakeholders with data-driven forecasts, regulatory insights, and competitive intelligence to navigate the evolving landscape of digital pathology solutions.

Study Overview

The Digital Pathology Market Study examines the global digital pathology market, segmented by product type (Scanners, Software, Information Management Systems, Storage & Cloud Solutions, Communication & Networking Systems), end-user (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), application (Drug Discovery and Development, Disease Diagnosis, Academic Research, Telepathology, Training & Education), and geography (North America, South America, Europe, Middle East and Africa, Asia Pacific). It includes robust analyses such as Porter's Five Forces Analysis, Industry Value Chain Analysis, and market share evaluations, alongside strategic recommendations and regulatory insights to help stakeholders capitalize on growth opportunities. The study highlights key driving factors, such as the adoption of AI in pathology and demand for remote diagnostics, and challenges, including high implementation costs and regulatory complexities.

Competitive Environment and Analysis

In the competitive intelligence section of the Digital Pathology Market Study, key players are highlighted for their strategic initiatives to strengthen market presence. For instance, Leica Biosystems Nussloch GmbH (Danaher) launched an upgraded version of its Aperio GT 450 DX scanner in 2024, featuring enhanced AI-driven image analysis for faster disease diagnosis in diagnostic laboratories across the United States. This development reinforces Leica Biosystems' leadership in high-throughput scanning solutions. Similarly, Koninklijke Philips N.V. expanded its digital pathology portfolio through a 2025 strategic collaboration with a leading European hospital network, integrating its IntelliSite platform with cloud-based storage solutions to enhance telepathology services in Germany and France. The study also includes market share analysis, mergers, acquisitions, and a competitive dashboard to provide a holistic view of the competitive landscape.

Conclusion

The Digital Pathology Market Study is an essential resource for industry experts seeking to understand the complexities of the digital pathology market. By offering detailed segmentation, technological outlooks, and competitive intelligence, this study provides a robust framework for identifying opportunities and formulating effective strategies. With leading players like Leica Biosystems Nussloch GmbH and Koninklijke Philips N.V. driving innovation in AI-enhanced scanning and cloud-integrated telepathology solutions, the Digital Pathology Market Study empowers stakeholders to stay competitive in this dynamic and rapidly growing industry.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Different segments covered under the digital pathology market report are as below:

By Product Type

  • Scanners
  • Software
  • Information Management Systems
  • Storage & Cloud Solutions
  • Communication & Networking Systems

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Application

  • Drug Discovery and Development
  • Disease Diagnosis
  • Academic Research
  • Telepathology
  • Training & Education

By Geography

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. DIGITAL PATHOLOGY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Scanners
  • 5.3. Software
  • 5.4. Information Management Systems
  • 5.5. Storage & Cloud Solutions
  • 5.6. Communication & Networking Systems

6. DIGITAL PATHOLOGY MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Diagnostic Laboratories
  • 6.4. Pharmaceutical & Biotechnology Companies
  • 6.5. Academic & Research Institutes
  • 6.6. Contract Research Organizations (CROs)

7. DIGITAL PATHOLOGY MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Drug Discovery and Development
  • 7.3. Disease Diagnosis
  • 7.4. Academic Research
  • 7.5. Telepathology
  • 7.6. Training & Education

8. DIGITAL PATHOLOGY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By End-User
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By End-User
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By End-User
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By End-User
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By End-User
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Leica Biosystems Nussloch GmbH (Danaher)
  • 10.2. Hamamatsu Photonics, Inc.
  • 10.3. Koninklijke Philips N.V.
  • 10.4. Olympus Corporation
  • 10.5. F. Hoffmann-La Roche Ltd.
  • 10.6. Mikroscan Technologies, Inc.
  • 10.7. Epredia (3DHISTECH Ltd.)
  • 10.8. Visiopharm A/S
  • 10.9. Huron Technologies International Inc.
  • 10.10. ContextVision AB

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations